Skip to main navigation Skip to search Skip to main content

ER stress and Rho kinase activation underlie the vasculopathy of CADASIL

Karla B. Neves, Adam P. Harvey, Fiona Moreton, Augusto C. Montezano, Francisco J. Rios, Rhéure Alves-Lopes, Aurelie Nguyen Dinh Cat, Paul Rocchicciolli, Christian Delles, Anne Joutel, Keith Muir, Rhian M. Touyz*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Downloads (Pure)

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) leads to premature stroke and vascular dementia. Mechanism-specific therapies for this aggressive cerebral small vessel disease are lacking. CADASIL is caused by NOTCH3 mutations that influence vascular smooth muscle cell (VSMC) function through unknown processes. We investigated molecular mechanisms underlying the vasculopathy in CADASIL focusing on endoplasmic reticulum (ER) stress and RhoA/Rho kinase (ROCK). Peripheral small arteries and VSMCs were isolated from gluteal biopsies of CADASIL patients and mesentery of TgNotch3R169C mice (CADASIL model). CADASIL vessels exhibited impaired vasorelaxation, blunted vasoconstriction, and hypertrophic remodeling. Expression of NOTCH3 and ER stress target genes was amplified and ER stress response, Rho kinase activity, superoxide production, and cytoskeleton-Associated protein phosphorylation were increased in CADASIL, processes associated with Nox5 upregulation. Aberrant vascular responses and signaling in CADASIL were ameliorated by inhibitors of Notch3 (-secretase inhibitor), Nox5 (mellitin), ER stress (4-phenylbutyric acid), and ROCK (fasudil). Observations in human CADASIL were recapitulated in TgNotch3R169C mice. These findings indicate that vascular dysfunction in CADASIL involves ER stress/ROCK interplay driven by Notch3-induced Nox5 activation and that NOTCH3 mutation associated vascular pathology, typical in cerebral vessels, also manifests peripherally. We define Notch3-Nox5/ER stress/ROCK signaling as a putative mechanism-specific target and suggest that peripheral artery responses may be an accessible biomarker in CADASIL.

Original languageEnglish
Article numbere131344
Number of pages22
JournalJCI Insight
Volume4
Issue number23
DOIs
Publication statusPublished - 5 Dec 2019

Funding

We thank Ying He and Elisabeth Beattie for helping with the myography experiments. We are also very grateful to the patients and volunteers who participated in this study. The authors are funded by grants from the British Heart Foundation (BHF) (RE/13/5/30177; BHF CoRE RE/18/6/34217) and the MRC (MC-PC-15076). The CADASIL biopsy samples were funded by grants from The Neurosciences Foundation and The Stroke Association (TSA 2013/02) and the control biopsy samples were funded by grants from the Department of Medicine, University of Ottawa and the Canadian Institutes of Health Research, Canada. RMT is supported through a BHF Chair award (CH/12/29762) and ACM is supported through a Walton Foundation fellowship, University of Glasgow.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CADASIL
  • vascular smooth muscle cell
  • endoplasmic reticulum (ER) stress
  • RhoA/Rho kinase (ROCK)

Fingerprint

Dive into the research topics of 'ER stress and Rho kinase activation underlie the vasculopathy of CADASIL'. Together they form a unique fingerprint.

Cite this